{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:37:43Z","timestamp":1793227063034,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003493","name":"Gemeinn\u00fctzige Hertie-Stiftung","doi-asserted-by":"publisher","award":["P1200014"],"award-info":[{"award-number":["P1200014"]}],"id":[{"id":"10.13039\/501100003493","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2021_EKMS.15"],"award-info":[{"award-number":["2021_EKMS.15"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pediatric neoplasms in the central nervous system (CNS) show extensive clinical and molecular heterogeneity and are fundamentally different from those occurring in adults. Molecular genetic testing contributes to accurate diagnosis and enables an optimal clinical management of affected children. Here, we investigated a rare, molecularly distinct type of pediatric high-grade neuroepithelial tumor (<jats:italic>n<\/jats:italic>\u2009=\u200918), that was identified through unsupervised visualization of genome-wide DNA methylation array data, together with copy number profiling, targeted next-generation DNA sequencing, and RNA transcriptome sequencing. DNA and\/or RNA sequencing revealed recurrent fusions involving the<jats:italic>capicua transcriptional repressor<\/jats:italic>(<jats:italic>CIC<\/jats:italic>) gene in 10\/10 tumor samples analyzed, with the most common fusion being<jats:italic>CIC::LEUTX<\/jats:italic>(<jats:italic>n<\/jats:italic>\u2009=\u20099). In addition, a<jats:italic>CIC::NUTM1<\/jats:italic>fusion was detected in one of the tumors. Apart from the detected fusion events, no additional oncogenic alteration was identified in these tumors. The histopathological review demonstrated a morphologically heterogeneous group of high-grade neuroepithelial tumors with positive immunostaining for markers of glial differentiation in combination with weak and focal expression of synaptophysin, CD56 and CD99. All tumors were located in the supratentorial compartment, occurred during childhood (median age 8.5 years) and typically showed early relapses. In summary, we expand the spectrum of pediatric-type tumors of the CNS by reporting a previously uncharacterized group of rare high-grade neuroepithelial tumors that share a common DNA methylation signature and recurrent gene fusions involving the transcriptional repressor<jats:italic>CIC<\/jats:italic>. Downstream functional consequences of the fusion protein<jats:italic>CIC::LEUTX<\/jats:italic>and potential therapeutic implications need to be further investigated.<\/jats:p>","DOI":"10.1038\/s41698-023-00372-1","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T10:03:44Z","timestamp":1679652224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3237-6021","authenticated-orcid":false,"given":"Philipp","family":"Sievers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schrimpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zied","family":"Abdullaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Donson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Friedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Scheie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Tynninen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomas","family":"Rauramaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisa L.","family":"Veps\u00e4l\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6850-4932","authenticated-orcid":false,"given":"David","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Grundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian W.","family":"Pajtler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnault","family":"Tauzi\u00e8de-Espariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"M\u00e9tais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Varlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matija","family":"Snuderl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Jacques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Aldape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Reuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Korshunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Wick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan M.","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5863-540X","authenticated-orcid":false,"given":"Andreas","family":"von Deimling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5441-1962","authenticated-orcid":false,"given":"Felix","family":"Sahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2036-5141","authenticated-orcid":false,"given":"David T. W.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,24]]},"reference":[{"key":"372_CR1","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","volume":"23","author":"QT Ostrom","year":"2021","unstructured":"Ostrom, Q. T., Cioffi, G., Waite, K., Kruchko, C. & Barnholtz-Sloan, J. S. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018. Neuro Oncol. 23, iii1\u2013iii105 (2021).","journal-title":"Neuro Oncol."},{"key":"372_CR2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1158\/2159-8290.CD-21-1094","volume":"12","author":"SM Pfister","year":"2022","unstructured":"Pfister, S. M. et al. A summary of the inaugural WHO classification of pediatric tumors: transitioning from the optical into the molecular era. Cancer Discov. 12, 331\u2013355 (2022).","journal-title":"Cancer Discov."},{"key":"372_CR3","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1093\/neuonc\/noab143","volume":"23","author":"D Pratt","year":"2021","unstructured":"Pratt, D., Sahm, F. & Aldape, K. DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncology. Neuro Oncol. 23, S16\u2013S29 (2021).","journal-title":"Neuro Oncol."},{"key":"372_CR4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00401-021-02356-6","volume":"142","author":"P Sievers","year":"2021","unstructured":"Sievers, P. et al. Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors. Acta Neuropathol. 142, 827\u2013839 (2021).","journal-title":"Acta Neuropathol."},{"key":"372_CR5","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00401-021-02354-8","volume":"142","author":"KT Alhalabi","year":"2021","unstructured":"Alhalabi, K. T. et al. PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum. Acta Neuropathol. 142, 841\u2013857 (2021).","journal-title":"Acta Neuropathol."},{"key":"372_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/ng.3500","volume":"48","author":"P Bandopadhayay","year":"2016","unstructured":"Bandopadhayay, P. et al. MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism. Nat. Genet. 48, 273\u2013282 (2016).","journal-title":"Nat. Genet."},{"key":"372_CR7","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00401-021-02369-1","volume":"142","author":"P Sievers","year":"2021","unstructured":"Sievers, P. et al. GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types. Acta Neuropathol. 142, 1065\u20131069 (2021).","journal-title":"Acta Neuropathol."},{"key":"372_CR8","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1158\/2159-8290.CD-19-1030","volume":"10","author":"M Clarke","year":"2020","unstructured":"Clarke, M. et al. Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes. Cancer Discov. 10, 942\u2013963 (2020).","journal-title":"Cancer Discov."},{"key":"372_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper, D. et al. DNA methylation-based classification of central nervous system tumours. Nature 555, 469\u2013474 (2018).","journal-title":"Nature"},{"key":"372_CR10","doi-asserted-by":"publisher","first-page":"e28028","DOI":"10.1002\/pbc.28028","volume":"67","author":"JA Lake","year":"2020","unstructured":"Lake, J. A. et al. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors. Pediatr. Blood Cancer 67, e28028 (2020).","journal-title":"Pediatr. Blood Cancer"},{"key":"372_CR11","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2016.01.015","volume":"164","author":"D Sturm","year":"2016","unstructured":"Sturm, D. et al. New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164, 1060\u20131072 (2016).","journal-title":"Cell"},{"key":"372_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35547-5","volume":"8","author":"S Katayama","year":"2018","unstructured":"Katayama, S. et al. Phylogenetic and mutational analyses of human LEUTX, a homeobox gene implicated in embryogenesis. Sci. Rep. 8, 17421 (2018).","journal-title":"Sci. Rep."},{"key":"372_CR13","doi-asserted-by":"publisher","first-page":"598970","DOI":"10.3389\/fonc.2020.598970","volume":"10","author":"W Hu","year":"2020","unstructured":"Hu, W. et al. Case Report: a unique case of pediatric central nervous system embryonal tumor harboring the CIC-LEUTX fusion, germline NBN variant and somatic TSC2 mutation: expanding the spectrum of CIC-rearranged neoplasia. Front. Oncol. 10, 598970 (2020).","journal-title":"Front. Oncol."},{"key":"372_CR14","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1242\/jcs.092965","volume":"125","author":"G Jimenez","year":"2012","unstructured":"Jimenez, G., Shvartsman, S. Y. & Paroush, Z. The Capicua repressor\u2014a general sensor of RTK signaling in development and disease. J. Cell Sci. 125, 1383\u20131391 (2012).","journal-title":"J. Cell Sci."},{"key":"372_CR15","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1126\/science.1210557","volume":"333","author":"C Bettegowda","year":"2011","unstructured":"Bettegowda, C. et al. Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 333, 1453\u20131455 (2011).","journal-title":"Science"},{"key":"372_CR16","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00401-012-0993-5","volume":"123","author":"F Sahm","year":"2012","unstructured":"Sahm, F. et al. CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas. Acta Neuropathol. 123, 853\u2013860 (2012).","journal-title":"Acta Neuropathol."},{"key":"372_CR17","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1097\/PAS.0000000000000846","volume":"41","author":"CR Antonescu","year":"2017","unstructured":"Antonescu, C. R. et al. Sarcomas with CIC-rearrangements are a distinct pathologic entity with aggressive outcome: a clinicopathologic and molecular study of 115 cases. Am. J. Surg. Pathol. 41, 941\u2013949 (2017).","journal-title":"Am. J. Surg. Pathol."},{"key":"372_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/gcc.20945","volume":"51","author":"A Italiano","year":"2012","unstructured":"Italiano, A. et al. High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas. Genes Chromosomes Cancer 51, 207\u2013218 (2012).","journal-title":"Genes Chromosomes Cancer"},{"key":"372_CR19","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1093\/hmg\/ddl136","volume":"15","author":"M Kawamura-Saito","year":"2006","unstructured":"Kawamura-Saito, M. et al. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum. Mol. Genet. 15, 2125\u20132137 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"372_CR20","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/gcc.22172","volume":"53","author":"K Specht","year":"2014","unstructured":"Specht, K. et al. Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities. Genes Chromosomes Cancer 53, 622\u2013633 (2014).","journal-title":"Genes Chromosomes Cancer"},{"key":"372_CR21","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1242\/dev.134510","volume":"143","author":"EM Jouhilahti","year":"2016","unstructured":"Jouhilahti, E. M. et al. The human PRD-like homeobox gene LEUTX has a central role in embryo genome activation. Development 143, 3459\u20133469 (2016).","journal-title":"Development"},{"key":"372_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9207","volume":"6","author":"V Tohonen","year":"2015","unstructured":"Tohonen, V. et al. Novel PRD-like homeodomain transcription factors and retrotransposon elements in early human development. Nat. Commun. 6, 8207 (2015).","journal-title":"Nat. Commun."},{"key":"372_CR23","doi-asserted-by":"publisher","unstructured":"Song, K., Huang, Y., Xia, C. D., Zhu, H. Q. & Wang, J. A case of CIC-rearranged sarcoma with CIC-LEUTX gene fusion in spinal cord. Neuropathology https:\/\/doi.org\/10.1111\/neup.12850 (2022).","DOI":"10.1111\/neup.12850"},{"key":"372_CR24","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 23, 1231\u20131251 (2021).","journal-title":"Neuro Oncol."},{"key":"372_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/ijc.32107","volume":"145","author":"A Christians","year":"2019","unstructured":"Christians, A., Poisel, E., Hartmann, C., von Deimling, A. & Pusch, S. Characterization of the epithelial membrane protein 3 interaction network reveals a potential functional link to mitogenic signal transduction regulation. Int. J. Cancer 145, 461\u2013473 (2019).","journal-title":"Int. J. Cancer"},{"key":"372_CR26","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee, M. J. et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30, 1363\u20131369 (2014).","journal-title":"Bioinformatics"},{"key":"372_CR27","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00401-015-1519-8","volume":"131","author":"F Sahm","year":"2016","unstructured":"Sahm, F. et al. Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets. Acta Neuropathol. 131, 903\u2013910 (2016).","journal-title":"Acta Neuropathol."},{"key":"372_CR28","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00401-019-02039-3","volume":"138","author":"D Stichel","year":"2019","unstructured":"Stichel, D. et al. Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions. Acta Neuropathol. 138, 827\u2013835 (2019).","journal-title":"Acta Neuropathol."},{"key":"372_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"372_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinforma. 12, 323 (2011).","journal-title":"BMC Bioinforma."},{"key":"372_CR31","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1101\/gr.257246.119","volume":"31","author":"S Uhrig","year":"2021","unstructured":"Uhrig, S. et al. Accurate and efficient detection of gene fusions from RNA sequencing data. Genome Res. 31, 448\u2013460 (2021).","journal-title":"Genome Res."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-023-00372-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-023-00372-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-023-00372-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T23:34:44Z","timestamp":1729121684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-023-00372-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["372"],"URL":"https:\/\/doi.org\/10.1038\/s41698-023-00372-1","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,24]]},"assertion":[{"value":"5 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M. Sill, D. Schrimpf, M. Snuderl, S.M.P., A.V.D., F.S., and D.T.W. J. are co-founders and shareholders in Heidelberg Epignostix, GmbH. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}